562 Appendices 83. Sapio MR, Posca D, Raggioli A, Guerra A, Marotta V, Deandrea M, et al. Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. Clinical endocrinology. 2007;66:678-683. https://doi.org/10.1111/j.1365-2265.2007.02800.x. 84. Kim SK, Kim DL, Han HS, Kim WS, Kim SJ, Moon WJ, et al. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules. Diagnostic molecular pathology : the American journal of surgical pathology, part B. 2008;17:118-125. https://doi.org/10.1097/PDM.0b013e31815d059d. 85. Jo YS, Huang S, Kim YJ, Lee IS, Kim SS, Kim JR, et al. Diagnostic value of pyrosequencing for the BRAF V600E mutation in ultrasound-guided fine-needle aspiration biopsy samples of thyroid incidentalomas. Clinical endocrinology. 2009;70:139-144. https://doi.org/10.1111/j.1365-2265.2008.03293.x. 86. Marchetti I, Lessi F, Mazzanti CM, Bertacca G, Elisei R, Coscio GD, et al. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates. Thyroid. 2009;19:837-842. https://doi.org/10.1089/thy.2009.0074. 87. Cantara S, Capezzone M, Marchisotta S, Capuano S, Busonero G, Toti P, et al. Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. The Journal of clinical endocrinology and metabolism. 2010;95:1365-1369. https://doi.org/10.1210/jc.2009-2103. 88. Moses W, Weng J, Sansano I, Peng M, Khanafshar E, Ljung BM, et al. Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy. World journal of surgery. 2010;34:2589-2594. https://doi.org/10.1007/s00268-010-0720-0. 89. Adeniran AJ, Theoharis C, Hui P, Prasad ML, Hammers L, Carling T, et al. Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study. Thyroid. 2011;21:717-723. https:// doi.org/10.1089/thy.2011.0021. 90. Patel A, Klubo-Gwiezdzinska J, Hoperia V, Larin A, Jensen K, Bauer A, et al. BRAF(V600E) mutation analysis from May-Grunwald Giemsa-stained cytological samples as an adjunct in identification of high-risk papillary thyroid carcinoma. Endocrine pathology. 2011;22:195-199. https://doi.org/10.1007/s12022-011-9180-9. 91. Canadas-Garre M, Becerra-Massare P, Lopez de la Torre-Casares M, Villar-del Moral J, Cespedes-Mas S, Vilchez-Joya R, et al. Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients. Annals of surgery. 2012;255:986-992. https://doi.org/10.1097/SLA.0b013e31824e8d70. 92. Kang G, Cho EY, Shin JH, Chung JH, Kim JW, Oh YL. Role of BRAFV600E mutation analysis and second cytologic review of fine-needle aspiration for evaluating thyroid nodule. Cancer cytopathology. 2012;120:44-51. https://doi. org/10.1002/cncy.20179. 93. Mancini I, Pinzani P, Pupilli C, Petrone L, De Feo ML, Bencini L, et al. A high-resolution melting protocol for rapid and accurate differential diagnosis of thyroid nodules. The Journal of molecular diagnostics. 2012;14:501-509. https:// doi.org/10.1016/j.jmoldx.2012.03.003. 94. Tonacchera M, Agretti P, Rago T, De Marco G, Niccolai F, Molinaro A, et al. Genetic markers to discriminate benign and malignant thyroid nodules with undetermined cytology in an area of borderline iodine deficiency. Journal of endocrinological investigation. 2012;35:754-759. https://doi.org/10.3275/8012. 95. Kloos RT, Reynolds JD, Walsh PS, Wilde JI, Tom EY, Pagan M, et al. Does addition of BRAF V600E mutation testing modify sensitivity or specificity of the Afirma Gene Expression Classifier in cytologically indeterminate thyroid nodules? The Journal of clinical endocrinology and metabolism. 2013;98:E761-768. https://doi.org/10.1210/jc.2012-3762. 96. Agretti P, Niccolai F, Rago T, De Marco G, Molinaro A, Scutari M, et al. BRAF mutation analysis in thyroid nodules with indeterminate cytology: our experience on surgical management of patients with thyroid nodules from an area of borderline iodine deficiency. Journal of endocrinological investigation. 2014;37:1009-1014. https://doi.org/10.1007/ s40618-014-0166-6. 97. Beaudenon-Huibregtse S, Alexander EK, Guttler RB, Hershman JM, Babu V, Blevins TC, et al. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules. Thyroid. 2014;24:1479-1487. https://doi.org/10.1089/thy.2013.0640. 98. Danilovic DL, Lima EU, Domingues RB, Brandao LG, Hoff AO, Marui S. Pre-operative role of BRAF in the guidance of the surgical approach and prognosis of differentiated thyroid carcinoma. European journal of endocrinology. 2014;170:619-625. https://doi.org/10.1530/eje-13-0944. 99. Eszlinger M, Krogdahl A, Munz S, Rehfeld C, Precht Jensen EM, Ferraz C, et al. Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules. Thyroid. 2014;24:305-313. https://doi.org/10.1089/thy.2013.0278. 100. Eszlinger M, Neustadt M, Ruschenburg I, Neumann A, Franzius C, Adam S, et al. [Fine-needle aspiration cytology of thyroid nodules: molecular diagnostics in a routine diagnostic setting]. Deutsche medizinische Wochenschrift. 2014;139:476-480. https://doi.org/10.1055/s-0034-1369883. 101. Johnson SJ, Hardy SA, Roberts C, Bourn D, Mallick U, Perros P. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology. Cytopathology. 2014;25:146-154. https://doi.org/10.1111/cyt.12125.
RkJQdWJsaXNoZXIy MTk4NDMw